Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for Adult T ‐cell Leukemia

This article is protected by copyright. All rights reserved.

Source: Cancer Science - October 1, 2017 Category: Cancer & Oncology Authors: Takahito Kawata, Kohei Tada, Masayuki Kobayashi, Takashi Sakamoto, Yoko Takiuchi, Fumie Iwai, Maki Sakurada, Masakatsu Hishizawa, Kotaro Shirakawa, Keisuke Shindo, Hironori Sato, Akifumi Takaori ‐Kondo Tags: Original Article Source Type: research